New Patent on Software Games for Depression
Summary
In recent years, brain training has emerged as a new pathway for treating neurological disorders by harnessing the brain’s plasticity — its natural ability to change chemically, structurally, and functionally.Typically, drugs for depression work by flooding the brain with a molecule that alters the action of a single, specific neurochemical pathway at all times.The exercises primarily work by demanding that a person pay attention to a series of images, responding to non-targets and withholding a response to targets.“This adds to our growing portfolio of patents in the areas of psychiatric disorders and social cognition,” said Dr. Henry Mahncke , CEO of Posit Science.As its research advances in clinical indications, Posit Science plans to approach appropriate regulatory agencies to explore the shortest path to getting a form of relevant exercises into the hands of patients who may be helped.